TY - JOUR
T1 - Suppression of endoplasmic reticulum stress-induced caspase activation and cell death by the overexpression of BCI-xL, or Bcl-2
AU - Murakami, Yayoi
AU - Aizu-Yokota, Eriko
AU - Sonoda, Yoshiko
AU - Ohta, Shigeo
AU - Kasahara, Tadashi
N1 - Funding Information:
The authors wish to thank Ms Eriko Takeuchi, Mr Daisaku Tagami and Mr Tomoyuki Ohshio for their technical assistance. This work was supported by Grant-in-Aids for Scientific Research (B), (C) and the High-Tech Research Center Project from The Ministry of Education Cultures, Sports, Science and Technology of Japan.
PY - 2007/3
Y1 - 2007/3
N2 - Continuous endoplasmic reticulum (ER) stress, such as the accumulation of unfolded proteins, results in cell death and relates to the pathogenesis of some neurodegenerative diseases. Treatment of brefeldin A, an inhibitor of transport between the ER and Golgi complex, induced cell death during 24h, which accompanied activation of caspase-2, caspase-3 and caspase-9, starting at 12h and increasing time-dependently up to 28h. Caspase-2 was expressed and activated in not only mitochondria and cytosol, but also in the microsomal fraction containing ER and Golgi. Of note is that overexpression of Bcl-xL or Bcl-2 in PC12 cells markedly suppressed brefeldin A-induced activation of caspases and resulting cell death. Delivery of anti-Bcl-2 antibody into the Bcl-2-overexpressed cells again recovered apoptosis. While the brefeldin A-treatment induced the phosphorylation of both c-Jun N-terminal kinase (JNK) and p38 MAPK, overexpression of Bcl-xL or Bcl-2 reduced the prolonged phosphorylation of JNK, but not of p38 MAPK. Pretreatment with a JNK inhibitor, SP600125, suppressed the brefeldin A-induced caspase-2 activation and cell death significantly. Thus, our results suggest that protective effects of Bcl-xL and Bcl-2 against brefeldin A-induced cell death appear to be dependent on the regulation of JNK activation.
AB - Continuous endoplasmic reticulum (ER) stress, such as the accumulation of unfolded proteins, results in cell death and relates to the pathogenesis of some neurodegenerative diseases. Treatment of brefeldin A, an inhibitor of transport between the ER and Golgi complex, induced cell death during 24h, which accompanied activation of caspase-2, caspase-3 and caspase-9, starting at 12h and increasing time-dependently up to 28h. Caspase-2 was expressed and activated in not only mitochondria and cytosol, but also in the microsomal fraction containing ER and Golgi. Of note is that overexpression of Bcl-xL or Bcl-2 in PC12 cells markedly suppressed brefeldin A-induced activation of caspases and resulting cell death. Delivery of anti-Bcl-2 antibody into the Bcl-2-overexpressed cells again recovered apoptosis. While the brefeldin A-treatment induced the phosphorylation of both c-Jun N-terminal kinase (JNK) and p38 MAPK, overexpression of Bcl-xL or Bcl-2 reduced the prolonged phosphorylation of JNK, but not of p38 MAPK. Pretreatment with a JNK inhibitor, SP600125, suppressed the brefeldin A-induced caspase-2 activation and cell death significantly. Thus, our results suggest that protective effects of Bcl-xL and Bcl-2 against brefeldin A-induced cell death appear to be dependent on the regulation of JNK activation.
KW - Bcl-2
KW - Caspase-2
KW - Cell death
KW - Endoplasmic reticulum stress
KW - JNK
UR - http://www.scopus.com/inward/record.url?scp=34248641140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34248641140&partnerID=8YFLogxK
U2 - 10.1093/jb/mvm044
DO - 10.1093/jb/mvm044
M3 - Article
C2 - 17301078
AN - SCOPUS:34248641140
SN - 0021-924X
VL - 141
SP - 401
EP - 410
JO - Journal of Biochemistry
JF - Journal of Biochemistry
IS - 3
ER -